(1)H HR-MAS NMR-Based Metabolomics of Cancer Cells in Response to Treatment with the Diruthenium Trithiolato Complex [(p-MeC(6)H(4)(i)Pr)(2)Ru(2)(SC(6)H(4)-p-Bu(t))(3)](+) (DiRu-1)

The trithiolato bridged diruthenium complex DiRu-1 [(p-MeC(6)H(4)(i)Pr)(2)Ru(2)(SC(6)H(4)-p-Bu(t))(3)](+) is highly cytotoxic against various cancer cell lines, but its exact mode of action remains unknown. The present (1)H HR-MAS NMR-based metabolomic study was performed on ovarian cancer cell line...

Descripción completa

Detalles Bibliográficos
Autores principales: Primasová, Hedvika, Paul, Lydia E. H., Diserens, Gaëlle, Primasová, Ester, Vermathen, Peter, Vermathen, Martina, Furrer, Julien
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6680816/
https://www.ncbi.nlm.nih.gov/pubmed/31323867
http://dx.doi.org/10.3390/metabo9070146

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6680816/
https://www.ncbi.nlm.nih.gov/pubmed/31323867
http://dx.doi.org/10.3390/metabo9070146

Ejemplares similares